Scholarly works
Posters
Outcomes Associated with Rate Control Strategies in Patients with Atrial Fibrillation and Heart Failure
Matthew G. Roth, PharmD Candidate; Maria F. Arlia, PharmD Candidate; Ashley K. Kegerreis, PharmD
Candidate; Katherine E. McGraw, PharmD Candidate; James Coons, PharmD, BCCP, FCCP
Safety Outcomes Associated with Rate-Controlling Medications to Manage Atrial Fibrillation in Patients with Heart Failure
Lydia Shen, PharmD Candidate; Adedeji Adeyiga, PharmD Candidate; Salvatore Richetti, PharmD Candidate;
Shay Roth, PharmD Candidate; James Coons, PharmD, BCCP, FCCP, FACC
Association between everolimus time-in therapeutic range and change in renal function in lung transplant recipients
Bethany Corry, PharmD Candidate; Ian Montelius, PharmD Candidate; Carolyn Ross, PharmD Candidate; Mary Zhuang, PharmD Candidate; Carlo Iasella, PharmD, MPH, BCPS
Association of Everolimus Time in Therapeutic Range on Progression of Chronic Lung Allograft Dysfunction in Lung Transplant Patients
Emily Flynn, PharmD Candidate; Madison Kornides, PharmD Candidate; Hannah Meek, PharmD Candidate;
Ethan Nguyen PharmD Candidate; Carlo Iasella, PharmD, MPH, BCPS, BCTXP
Publications
Bhalodia NJ, White EM, Achanta A, Cheng J, Deri CR, Stahl K, Heiney H, Marchionda O, Iasella CJ, Coons JC. DOAC Dosing Discordance Using Different Estimates of Kidney Function and Outcomes. J Clin Pharmacol. 2023 Sep;63(9):1061-1066. doi: 10.1002/jcph.2283. Epub 2023 Jun 6.
PMID: 37178305
Coons JC, Iasella CJ, Thornberg M, Fitzmaurice MG, Goehring K, Jablonski L, Leader D, Meyer A, Seo H, Benedict NJ, Smith RE. Clinical outcomes with unfractionated heparin monitored by anti-factor Xa vs. activated partial Thromboplastin time. Am J Hematol. 2019 Sep;94(9):1015-1019. doi: 10.1002/ajh.25565. Epub 2019 Jul 16.
PMID: 31243789
Coons JC, Iasella CJ, Chanas T, Wang N, Williams K, Boyd A, Lyons J, Eckardt J, Rihtarchik L, Merkel A, Chambers A, Lemon LS, Smith R, Ensor CR. Comparative Effectiveness and Safety Analysis of Dual Antiplatelet Therapies Within an Integrated Delivery System. Ann Pharmacother. 2017 Aug;51(8):649-655. doi: 10.1177/1060028017706977. Epub 2017 Apr 24.
PMID: 28438043